Detailed information for compound 55875

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 476.463 | Formula: C19H20N6O7S
  • H donors: 6 H acceptors: 10 LogP: 0.06 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 2
  • SMILES: OC(=O)C(NC(=O)c1ccc(cc1)NCc1cnc2c(c1)c(O)nc(n2)N)CCS(=O)(=O)O
  • InChi: 1S/C19H20N6O7S/c20-19-24-15-13(17(27)25-19)7-10(9-22-15)8-21-12-3-1-11(2-4-12)16(26)23-14(18(28)29)5-6-33(30,31)32/h1-4,7,9,14,21H,5-6,8H2,(H,23,26)(H,28,29)(H,30,31,32)(H3,20,22,24,25,27)
  • InChiKey: DEZOURQTRLKTPD-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens dihydrofolate reductase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum ko:K00287 dihydrofolate reductase [EC1.5.1.3], putative Get druggable targets OG5_128410 All targets in OG5_128410
Echinococcus granulosus dihydrofolate reductase Get druggable targets OG5_128410 All targets in OG5_128410
Mycobacterium tuberculosis Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) Get druggable targets OG5_128410 All targets in OG5_128410
Candida albicans hypothetical protein Get druggable targets OG5_128410 All targets in OG5_128410
Mycobacterium ulcerans dihydrofolate reductase DfrA Get druggable targets OG5_128410 All targets in OG5_128410
Echinococcus multilocularis dihydrofolate reductase Get druggable targets OG5_128410 All targets in OG5_128410
Chlamydia trachomatis dihydrofolate reductase Get druggable targets OG5_128410 All targets in OG5_128410
Mycobacterium leprae DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) Get druggable targets OG5_128410 All targets in OG5_128410
Candida albicans dihydrofolate reductase Get druggable targets OG5_128410 All targets in OG5_128410
Loa Loa (eye worm) dihydrofolate reductase Get druggable targets OG5_128410 All targets in OG5_128410
Candida albicans dihydrofolate reductase Get druggable targets OG5_128410 All targets in OG5_128410
Schistosoma mansoni dihydrofolate reductase Get druggable targets OG5_128410 All targets in OG5_128410
Brugia malayi Dihydrofolate reductase Get druggable targets OG5_128410 All targets in OG5_128410
Brugia malayi dihydrofolate reductase family protein Get druggable targets OG5_128410 All targets in OG5_128410

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase dihydrofolate reductase 187 aa 202 aa 29.7 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus voltage dependent calcium channel type d subunit|voltage dependent calcium channel alpha 1 0.0275 0.6583 1
Echinococcus granulosus voltage dependent calcium channel type d subunit|voltage dependent calcium channel|voltage dependent L type calcium channel subu 0.0275 0.6583 1
Brugia malayi Voltage-gated calcium channel, L-type, alpha subunit. C. elegans egl-19 ortholog 0.0275 0.6583 0.4111
Mycobacterium leprae DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) 0.0208 0.4198 0.5
Echinococcus multilocularis voltage dependent calcium channel 0.0275 0.6583 1
Echinococcus multilocularis voltage dependent L type calcium channel subunit 0.0275 0.6583 1
Trypanosoma cruzi C-8 sterol isomerase, putative 0.0373 1 1
Schistosoma mansoni voltage-gated cation channel 0.0275 0.6583 1
Echinococcus granulosus voltage dependent calcium channel 0.0275 0.6583 1
Trypanosoma brucei C-8 sterol isomerase, putative 0.0373 1 1
Mycobacterium ulcerans dihydrofolate reductase DfrA 0.0208 0.4198 0.5
Echinococcus multilocularis voltage dependent calcium channel type d subunit 0.0275 0.6583 1
Mycobacterium tuberculosis Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) 0.0208 0.4198 0.5
Schistosoma mansoni high voltage-activated calcium channel Cav1 0.0275 0.6583 1
Chlamydia trachomatis dihydrofolate reductase 0.0208 0.4198 0.5
Echinococcus multilocularis dihydrofolate reductase 0.0208 0.4198 0.6377
Loa Loa (eye worm) hypothetical protein 0.0275 0.6583 0.4666
Loa Loa (eye worm) dihydrofolate reductase 0.0208 0.4198 0.0942
Echinococcus granulosus voltage dependent L type calcium channel subunit|voltage dependent calcium channel 0.0275 0.6583 1
Echinococcus granulosus dihydrofolate reductase 0.0208 0.4198 0.6377
Echinococcus multilocularis voltage dependent calcium channel 0.0275 0.6583 1
Echinococcus multilocularis voltage dependent L type calcium channel subunit 0.0275 0.6583 1
Loa Loa (eye worm) calcium channel 0.0275 0.6583 0.4666
Echinococcus multilocularis voltage dependent calcium channel type d subunit 0.0275 0.6583 1
Loa Loa (eye worm) hypothetical protein 0.0373 1 1
Schistosoma mansoni high voltage-activated calcium channel Cav2A 0.0275 0.6583 1
Leishmania major C-8 sterol isomerase-like protein 0.0373 1 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.4 uM Compound was tested in vitro for the inhibition of human dihydrofolate reductase (DHFR) ChEMBL. 1578484
IC50 (binding) = 0.4 uM Compound was tested in vitro for the inhibition of human dihydrofolate reductase (DHFR) ChEMBL. 1578484
IC50 (binding) = 55 uM Compound was tested in vitro for the inhibition of human thymidylate synthase (TS) ChEMBL. 1578484
IC50 (binding) = 55 uM Compound was tested in vitro for the inhibition of human thymidylate synthase (TS) ChEMBL. 1578484
Ki (binding) = 570 uM Compound was tested in vitro for the inhibition of mouse liver Folyl-polyglutamate synthase ChEMBL. 1578484
Ki (binding) = 570 uM Compound was tested in vitro for the inhibition of mouse liver Folyl-polyglutamate synthase ChEMBL. 1578484

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.